UMB Bank’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$71.7M Sell
77,979
-661
-0.8% -$670K 1% 23
2025
Q4
$84.5M Sell
78,640
-1,146
-1% -$1.1M 1.12% 16
2025
Q3
$60.9M Sell
79,786
-8,058
-9% -$6M 0.9% 27
2025
Q2
$68.5M Sell
87,844
-2,382
-3% -$1.85M 1.07% 20
2025
Q1
$74.5M Sell
90,226
-4,399
-5% -$3.66M 1.23% 20
2024
Q4
$73.1M Sell
94,625
-23,237
-20% -$19.2M 1.16% 19
2024
Q3
$104M Sell
117,862
-2,966
-2% -$2.67M 1.63% 13
2024
Q2
$109M Sell
120,828
-3,363
-3% -$2.69M 1.79% 10
2024
Q1
$96.6M Sell
124,191
-9,487
-7% -$6.75M 1.53% 14
2023
Q4
$77.9M Sell
133,678
-15,981
-11% -$9.33M 1.14% 21
2023
Q3
$80.4M Sell
149,659
-20,935
-12% -$10.8M 1.29% 17
2023
Q2
$80M Sell
170,594
-1,526
-0.9% -$640K 1.21% 17
2023
Q1
$59.1M Buy
172,120
+479
+0.3% +$162K 0.95% 25
2022
Q4
$62.8M Sell
171,641
-657
-0.4% -$233K 0.99% 20
2022
Q3
$55.7M Sell
172,298
-2,285
-1% -$724K 0.94% 20
2022
Q2
$56.6M Buy
174,583
+7,156
+4% +$2.15M 0.88% 23
2022
Q1
$47.9M Buy
167,427
+109,753
+190% +$28.2M 0.63% 36
2021
Q4
$15.9M Buy
57,674
+31,263
+118% +$7.93M 0.2% 108
2021
Q3
$6.1M Sell
26,411
-1,579
-6% -$390K 0.14% 135
2021
Q2
$6.42M Buy
27,990
+2,930
+12% +$589K 0.15% 126
2021
Q1
$4.68M Buy
25,060
+1,716
+7% +$336K 0.11% 132
2020
Q4
$3.94M Sell
23,344
-2,024
-8% -$302K 0.11% 135
2020
Q3
$4.17M Hold
25,368
0.13% 130
2020
Q2
$4.17M Sell
25,368
-61
-0.2% -$9.36K 0.13% 130
2020
Q1
$3.53M Sell
25,429
-563
-2% -$77.4K 0.13% 128
2019
Q4
$3.42M Sell
25,992
-137
-0.5% -$15.9K 0.09% 144
2019
Q3
$2.92K Sell
26,129
-11,021
-30% -$1.23M 0.07% 152
2019
Q2
$4.12K Buy
37,150
+109
+0.3% +$12.8K 0.1% 135
2019
Q1
$4.81M Sell
37,041
-146
-0.4% -$17.8K 0.15% 121
2018
Q4
$4.3K Sell
37,187
-4,818
-11% -$538K 0.13% 114
2018
Q3
$4.51M Buy
42,005
+13,138
+46% +$1.31M 0.13% 126
2018
Q2
$2.46M Sell
28,867
-4,225
-13% -$347K 0.08% 152
2018
Q1
$2.56M Sell
33,092
-2,391
-7% -$192K 0.08% 151
2017
Q4
$3M Sell
35,483
-1,187
-3% -$101K 0.1% 142
2017
Q3
$3.14M Sell
36,670
-297
-0.8% -$24.4K 0.11% 137
2017
Q2
$3.04M Sell
36,967
-681
-2% -$55.6K 0.11% 138
2017
Q1
$3.17M Sell
37,648
-106
-0.3% -$8.49K 0.11% 137
2016
Q4
$2.78M Sell
37,754
-19,336
-34% -$1.44M 0.1% 140
2016
Q3
$4.58M Sell
57,090
-9,500
-14% -$760K 0.18% 107
2016
Q2
$5.24M Sell
66,590
-118,080
-64% -$8.89M 0.22% 94
2016
Q1
$13.3M Buy
184,670
+1,340
+0.7% +$101K 0.57% 57
2015
Q4
$15.4M Sell
183,330
-16,557
-8% -$1.37M 0.67% 41
2015
Q3
$16.7M Buy
199,887
+62,530
+46% +$5.28M 0.98% 23
2015
Q2
$11.5K Buy
137,357
+12,016
+10% +$916K 0.53% 54
2015
Q1
$9.11K Buy
125,341
+98,085
+360% +$6.98M 0.41% 64
2014
Q4
$1.88M Sell
27,256
-621
-2% -$41.9K 0.08% 144
2014
Q3
$1.81K Sell
27,877
-732
-3% -$46.3K 0.09% 140
2014
Q2
$1.78M Sell
28,609
-500
-2% -$29.8K 0.08% 143
2014
Q1
$1.71M Buy
29,109
+310
+1% +$17.3K 0.1% 139
2013
Q4
$1.47K Sell
28,799
-228
-0.8% -$11.4K 0.08% 145
2013
Q3
$1.46K Buy
29,027
+17
+0.1% +$890 0.08% 145
2013
Q2
$1.43K Buy
+29,010
New +$1.58M 0.08% 145

Other funds holding LLY

UMB Bank's LLY Position: Q1 2026 in Review

UMB Bank reduced its Eli Lilly (LLY) stake by 0.84% in Q1 2026, selling an estimated $670K and leaving 77,979 shares worth $71.7M. The position accounts for 1% of the portfolio, ranked #23.

UMB Bank first reported a position in LLY in Q2 2013 and has held it in 52 quarters since. The position peaked at $109M in Q2 2024. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • UMB Bank held 77,979 shares of Eli Lilly worth $71.7M as of Q1 2026.
  • UMB Bank sold 661 Eli Lilly shares in Q1 2026, an estimated $670K.
  • Eli Lilly made up 1% of UMB Bank's portfolio in Q1 2026, its #23 holding.
  • UMB Bank first reported a position in Eli Lilly in Q2 2013 and has held it in 52 quarters since.
  • UMB Bank's Eli Lilly position peaked at $109M in Q2 2024.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on UMB Bank's 13F filing for Q1 2026, filed 11 May 2026.